|
Aug 8
|
Paramount, Rocket, and More Stocks See Action From Activist Investors
|
|
Aug 7
|
High Insider Ownership Growth Stocks To Watch In August 2025
|
|
Aug 7
|
Top Growth Companies With Insider Ownership In August 2025
|
|
Aug 4
|
ARS Pharmaceuticals Announces Conference Call and Webcast for its Second Quarter 2025 Financial Results
|
|
Jul 31
|
Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates
|
|
Jul 31
|
Here's What Could Help ARS Pharmaceuticals, Inc. (SPRY) Maintain Its Recent Price Strength
|
|
Jul 30
|
July 2025's Leading Growth Companies With Strong Insider Commitment
|
|
Jul 30
|
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Jul 30
|
Niagen Bioscience And Two Other High Growth Stocks With Strong Insider Ownership
|
|
Jul 29
|
Analysts Estimate ARS Pharmaceuticals, Inc. (SPRY) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 28
|
Discover LifeMD And 2 Other High Growth Stocks With Strong Insider Ownership
|
|
Jul 28
|
Three Growth Stocks With Strong Insider Confidence
|
|
Jul 24
|
High Insider Confidence In These Growth Stocks For July 2025
|
|
Jul 23
|
Top Growth Companies With Insider Stake In July 2025
|
|
Jul 23
|
Bank First And 2 Growth Stocks Insiders Are Holding Tight
|
|
Jul 21
|
Top Growth Companies With Insider Stakes July 2025
|
|
Jul 21
|
3 Growth Companies With High Insider Ownership Expecting 23% Revenue Growth
|
|
Jul 18
|
MHRA approves needle-free adrenaline nasal spray for anaphylaxis
|
|
Jul 18
|
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
|
|
Jul 15
|
ARS Pharmaceuticals, Inc. (SPRY) is a Great Momentum Stock: Should You Buy?
|